ARCHIVES

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

This article is from The Cancer Letter archive.

Vol. 23 No. 19 | May 16, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Coffin, McIntosh Named Cancer Society Research Professors

February 11, 1994

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

In Brief: NCAB Meeting Set For Oct. 3-5; Second Workshop On Tumor Cell Cloning Jan. 3-5

August 24, 1979